Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
ClinicalTrials.gov study NCT00896701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00806325. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02204085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy
ClinicalTrials.gov study NCT02226497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05580601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01137747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05017883. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aerobic Versus Resistive Training on Functional Capacity in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04617145. IPD Sharing: NO. Countries: 1. Publications: 0.
Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies
ClinicalTrials.gov study NCT05123352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2
ClinicalTrials.gov study NCT03338348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07036250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06401603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00641030. IPD Sharing: Not stated. Countries: 1. Publications: 0.
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07007949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients
ClinicalTrials.gov study NCT04168138. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06068868. IPD Sharing: NO. Countries: 5. Publications: 0.
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05597306. IPD Sharing: NO. Countries: 1. Publications: 0.
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00006240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06387420. IPD Sharing: NO. Countries: 1. Publications: 0.
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05726110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.